MedPage Today on MSN
FDA Approves Generic Flovent Inhaler for Asthma
Move comes 2 years after controversial exit of brand-name product ...
Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and Nasal Drug Products (OINDPs) and Ophthalmic ...
Key market opportunities in the inhaler solution market include the rising demand driven by increased respiratory disorders like asthma and COPD, expanding access to medicines in low and middle-income ...
The drug has been granted a Competitive Generic Therapy designation by the US FDA. Glenmark is recognized as the first ...
New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...
(Reuters) -Liquidia has filed a legal challenge to the U.S. Food and Drug Administration's decision to grant a three-year exclusivity to United Therapeutics' inhaled drug used to treat lung disorders, ...
ATLANTA - Prices are rising sharply on many asthma inhalers just in time for spring allergy season and some insurance companies are not covering the higher costs, and many patients cannot afford the ...
In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist five patents from the Food and Drug Administration (FDA)’s ...
Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...
WASHINGTON (Reuters) - A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported on Thursday, and can also protect ...
Stock prices for Alexza Pharmaceuticals Inc. recently surged by 25% to 78 cents. This came after the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee conditionally backed ...
(Reuters) - Evoke Pharma Inc said its inhaled version of a generic gastrointestinal drug was found to be superior in managing symptoms of bowel disease compared with the existing oral treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results